Business Context and Reporting Period
Company: Retractable Technologies, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 28, 2021 (Signed June 3, 2021)
Context: The filing reports the entry into a material definitive agreement and other events regarding government contracts with the U.S. Department of Health and Human Services.
Key Financial Metrics
This Form 8-K does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity figures. The filing focuses exclusively on contractual amendments and notices.
Material Changes
- Contract Amendment: Effective May 28, 2021, the Company amended a delivery order originally awarded on May 1, 2020, from the U.S. Department of Health and Human Services.
- Performance Period: The end date for the period of performance was extended from May 2021 to March 2022.
- Product Reallocation: The amendment reallocates ordered products to increase shipments of 1mL low dead-space safety syringes.
- Contract Extension Notice: On June 1, 2021, the Company received a notice regarding the extension of a government contract.
Guidance, Outlook, and Risks
Management Commentary: The filing references press releases (Exhibits 99.1 and 99.2) announcing the amendment and the contract extension notice but does not include detailed management commentary, forward-looking guidance, or specific risk factors within the text of this report.
Unusual Items: None reported in this filing.
Investor Verification Checklist
- Verify the total value of the amended delivery order and the specific volume of 1mL low dead-space safety syringes to be shipped.
- Review the attached press releases (Exhibits 99.1 and 99.2) for details on the financial impact of the contract extension.
- Confirm the terms of the extension notice received on June 1, 2021, including any new performance obligations.